Allen Williams

Exactech Revolutionizes Ankle Implants with Activit-E™ Polyethylene: Enhancing the Vantage® Total Ankle System” Exactech, a trailblazer in innovative joint replacement solutions, has received FDA 510(k) … Read more

MicroVention Makes Waves in Neurovascular Advancements: FDA Gives Green Light to SOFIA™ EX 5F Catheter for Transradial Access ALISO VIEJO, Calif.–(BUSINESS WIRE)– In a groundbreaking … Read more

NEW YORK, Sept. 21, 2023 /PRNewswire/ — Transcend Therapeutics, the visionary biotech on a mission to revolutionize neuropsychiatric treatments, proudly announces a transformative partnership with … Read more

OAKLAND, Calif., Sept. 21, 2023 /PRNewswire/ — Aditum Bio, the brainchild of former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for … Read more

In the dynamic world of biopharmaceutical manufacturing, the hunger for skilled professionals is surging ahead, but the talent pool is struggling to keep pace. This … Read more

In a stunning display of commitment to innovation, Roche’s Genentech has unleashed a flurry of R&D deals, including a high-stakes partnership with Orionis Biosciences worth … Read more

A groundbreaking analysis published in NEJM Catalyst reveals how Civica Rx, a not-for-profit drug manufacturer, has transformed the landscape of drug supply security while dramatically … Read more

In a thrilling twist, the FDA has accepted Alvotech’s latest Biologics License Application (BLA) for AVT02, a high-concentration and interchangeable biosimilar aiming to dethrone AbbVie’s … Read more

In a remarkable twist of fate, Mesoblast has emerged from the shadows with renewed determination, claiming a newfound understanding of the FDA’s demands following a … Read more

Travere Therapeutics made waves on Thursday with a dramatic Phase III showdown for its kidney disease wonder drug, sparsentan, affectionately known as Filspari. The stage … Read more

Rezo Therapeutics, a trailblazing biotech firm revolutionizing disease mapping for targeted therapeutics, makes waves with the appointment of Dr. Nadir Mahmood as the dynamic Chief … Read more

HONG KONG and NANJING, China, Sept. 20, 2023 /PRNewswire/ — In a groundbreaking development, Hepagene Therapeutics, Inc., a visionary clinical-stage biopharmaceutical powerhouse, proudly announces the … Read more

BOULDER, Colo., Sept. 20, 2023 (GLOBE NEWSWIRE) — In an exciting move, OnKure, Inc., a dynamic clinical-stage biopharmaceutical company shaping the future of precision oncology, … Read more

Compared to the IPO bonanzas of recent years, 2023 has felt like a chilly desert in the biotech world. In 2022, a whopping 47 IPOs … Read more

In a somber turn of events, Colorado-based pharma Fresh Tracks and California biotech Histogen have both declared their intentions to dissolve and liquidate their businesses. … Read more

Eli Lilly isn’t holding back as it takes the legal battlefield by storm, aiming to protect its flagship drug, Mounjaro. The pharmaceutical giant is unleashing … Read more

In a financial triumph, ReCode Therapeutics has just concluded a dazzling extension round for its Series B funding, raking in an additional $50 million. This … Read more

In a surprising twist, the FDA dealt a setback to ARS Pharmaceuticals on Tuesday by rejecting its application for the groundbreaking epinephrine nasal spray known … Read more

In a thrilling development, Japanese biopharma powerhouse PeptiDream has announced yet another groundbreaking partnership, this time with Genentech, a subsidiary of Roche, with a jaw-dropping … Read more

In a surprising turn of events, Taysha Gene Therapies has decided to part ways with its leading experimental AAV-based gene therapy candidate, TSHA-120, following the … Read more

Kathleen P. Bloch Returns to the Helm as Full-Time CFO at CytoSorbents – A Strategic Move for an Exciting Future! PRINCETON, N.J., Sept. 19, 2023 … Read more

Exciting News from Amsterdam: Nostics Welcomes Seasoned Medtech Innovator, Jeroen Nieuwenhuis, as CEO Amsterdam, September 19, 2023 – Nostics, a groundbreaking medical diagnostics startup, is … Read more

Akoya Biosciences Unleashes Breakthrough 2.0 Platforms, Paving the Way for Unprecedented Advancements in Spatial Biology MARLBOROUGH, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences … Read more

Revolution Medicines Launches Clinical Journey for Groundbreaking Cancer Treatment: First Patient Dosed in Trial of RMC-9805, a Game-Changing KRASG12D(ON) Inhibitor REDWOOD CITY, Calif., Sept. 19, … Read more

Unlocking a Powerful Weapon Against Liver Cancer: Hepion Pharmaceuticals’ Breakthrough Discovery EDISON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — In a groundbreaking revelation, Hepion Pharmaceuticals, … Read more

Hope on the Horizon: Orchard Therapeutics’ Breakthrough Gene Therapy for Rare Disease Gains FDA Priority Review In a game-changing move, the FDA has given the … Read more

Sanofi’s Strategic Shake-Up: 11 CNS Drugs, Including Frisium and Gardenal, Find a New Home with Pharmanovia In a bold move on Monday, Sanofi parted ways … Read more

Astellas Pharma’s Izervay, an eye injection treatment, is on a rapid ascent just six weeks after gaining FDA approval. Now, the company has set its … Read more

Novartis Makes a Strategic Pivot: Returns Cancer Drug Tislelizumab to BeiGene as Europe Approves Tevimbra In a noteworthy twist of pharmaceutical fate, Novartis has handed … Read more

In a surprising turn of events on September 1, the U.S. Federal Trade Commission gave the green light to Amgen’s colossal $27.8 billion takeover of … Read more

B. Braun Introduces Revolutionary Dialysis Solution: AQUAbase nX – Purity without Chemicals BETHLEHEM, Pa., Sept. 18, 2023 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), … Read more

BOSTON, Sept. 18, 2023 /PRNewswire/ — Unravel Biosciences, Inc., (“Unravel”), a pioneer in therapeutics powered by cutting-edge machine learning, is set to revolutionize the landscape … Read more

Revolutionizing Hemophilia Care: Precision BioLogic’s Breakthrough CRYOcheck™ Factor VIII Deficient Plasma Now FDA-Cleared for U.S. Market Halifax, NS – September 18, 2023 – Precision BioLogic … Read more

Revolutionizing Mental Health Treatment: Tiny Brain Stimulator Offers Hope for Treatment-Resistant Depression HOUSTON–(BUSINESS WIRE)–In a groundbreaking collaboration between Motif Neurotech, Rice University, Baylor College of … Read more

SAN JOSE, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a trailblazing biotherapeutics company, is embarking … Read more

Karyopharm Therapeutics: Navigating a Complex Path to Expansion for Selinexor Since Karyopharm Therapeutics secured accelerated FDA approval for selinexor in combination with dexamethasone for relapsed … Read more

High-Stakes Legal Clash: DOJ and Chamber of Commerce Face Off in Ohio Court Over IRA’s Drug Price Negotiations In a riveting courtroom battle, lawyers for … Read more

FDA Grants Green Light to GSK’s Ojjaara: A Game-Changer for Myelofibrosis Patients Battling Anemia! In a monumental decision on Friday, the FDA gave the nod … Read more

In a sensational twist, Anthos Therapeutics has decided to halt its Phase II AZALEA-TIMI 71 study prematurely. The reason is their experimental monoclonal antibody, abelacimab, … Read more

In a whirlwind year of groundbreaking partnerships, Samsung Biologics is making waves in the biotech world. The South Korean powerhouse has just expanded its collaboration … Read more

July marked a pivotal moment in the quest to combat the devastating impact of substance use disorders (SUD). The FDA gave the green light to … Read more

AstraZeneca’s Alexion Resolves Long-Standing Legal Saga: $125M Settlement in Soliris Sales Battle! In a legal faceoff that has spanned several years, AstraZeneca’s rare diseases arm, … Read more

Biotech IPOs Roar Back to Life: RayzeBio and Neumora’s Combined $560M Triumph Signals a Resurgence! In a thrilling twist for the world of initial public … Read more

Game-Changer Alert: Blarcamesine by Anavex Shows Remarkable Promise in Slowing Alzheimer’s Cognitive Decline! In a remarkable turn of events, Anavex Life Sciences has revealed that … Read more

Sandoz Gears Up for Independence: Novartis Shareholders Give the Nod to Epic Spin-Off! After a year-long journey toward independence, Sandoz, Novartis’ generics and biosimilars division, … Read more

Biotech Finance: Riding the Wave of Resurgence – Big IPOs, Bold Moves, and Regulatory Drama! The biotech sector is buzzing with excitement as a shift … Read more

ATHENS, Greece, Sept. 18, 2023 /PRNewswire/ — In a groundbreaking revelation, a new class of drugs called Senolytics is emerging as the savior in the … Read more

HANGZHOU, China – Sept. 18, 2023 – In a thrilling turn of events, Zylox-Tonbridge (2190.HK, fondly known as “the Company”) has just secured a spot … Read more

INCHEON, South Korea – Sept. 17, 2023 – Today, in a groundbreaking move, Samsung Biologics (KRX: 207940.KS) has unveiled a strategic alliance that promises to … Read more

In an era where the life sciences industry undergoes a rapid digital evolution, the debut of BioTechX USA in sunny Santa Clara this September was … Read more

Fresenius Kabi Partners with Virginia Oncology Associates to Revolutionize Patient Care: Introducing the Ivenix Infusion System for Enhanced Medication Delivery LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi … Read more

Unlocking Opportunities: Pasithea Therapeutics Corp. Empowers Stockholders with Successful Tender Offer PALO ALTO, Calif. and MIAMI, Sept. 14, 2023 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. … Read more

Unveiling the Genetic Tango: How Variants in Our DNA Choreograph Cardiovascular Health REYKJAVIK, Iceland, Sept. 14, 2023 /PRNewswire/ — Step into the captivating world of … Read more

OKYO Pharma’s Bold Move: Pulls the Plug on Public Offering Amid Shifting Market Tides LONDON and NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) — OKYO … Read more

Cancer’s Mismatched Battle: Unmasking the Surprising Key to Effective Immunotherapy In the realm of cancer immunotherapy, the assumption has long been that more genetic mutations … Read more

Breaking Ground in Respiratory Care: Oxford’s AlveoGene Unveils Vision for Inhaled Gene Therapies In a groundbreaking debut, Oxford-based biotech AlveoGene has burst onto the scene, … Read more

AbbVie Opts Out of Exclusive License for Harpoon’s Innovative Multiple Myeloma Therapy In a surprising twist, AbbVie has decided not to exercise its exclusive licensing … Read more

Moderna Drops Four Clinical Initiatives, Rescuing Two Left Adrift by AstraZeneca In a strategic shake-up, Moderna made waves on Wednesday by trimming its clinical development … Read more

In a major funding coup, AI-centric startup Generate:Biomedicines has scored an impressive $273 million windfall in its Series C financing round, thanks to the backing … Read more

Bristol Myers Squibb, in a bold move unveiled during an R&D Day event, has pruned its development portfolio by axing two mid-stage and shelving four … Read more

WILMINGTON, Del.—In a groundbreaking move, Uvax Bio LLC, the trailblazing vaccine biotechnology firm renowned for its cutting-edge 1c-SApNP® vaccine design platform, has welcomed Dr. Pedro … Read more

LAGUNA HILLS, Calif., Sept. 13, 2023 /PRNewswire/ — In a monumental stride towards revolutionizing heart care, Adagio Medical, Inc. has taken the world of cardiac … Read more

On a fateful day in late June, Gilead Sciences made waves in the biopharmaceutical world with a bold financial move. They acquired a staggering 3 … Read more

Neurocrine’s Breakthrough: Hope on the Horizon for Congenital Adrenal Hyperplasia as Phase III Trial Succeeds In a significant stride forward, Neurocrine Biosciences has unveiled the … Read more

Skyrizi Triumphs Over Stelara: AbbVie’s Breakthrough in Crohn’s Disease Trial In a head-to-head showdown, AbbVie’s Skyrizi (risankizumab) has not only matched but potentially outpaced Johnson … Read more

Eiger Halts Phase III Hepatitis Study Amid Safety Concerns, Sending Stocks Tumbling Eiger BioPharmaceuticals dropped a bombshell on Tuesday, announcing the abrupt discontinuation of its … Read more

Moderna’s Ambitious Leap Beyond COVID: Unveils Plan for 15 New Medicines in the Next 5 Years In a bold move to diversify beyond its COVID-19 … Read more

Adcomm Backs Alnylam’s Heart Disease Drug Despite FDA Concerns: A Close Vote with Patient Perspective in Focus” In a closely-watched decision, the FDA’s Cardiovascular and … Read more

In the dynamic realm of biomedical sciences, postdoctoral positions are often regarded as the stepping stones for freshly minted PhDs, offering pathways into promising careers … Read more

Amid the pandemic, the rise of virtual job fairs was nothing short of a game-changer, especially in the realm of higher education and the pharmaceutical … Read more

CARGO Therapeutics Welcomes Dr. Michael Ports as Chief Scientific Officer, Pioneering the Future of Cell Therapy for Cancer” Dr. Michael Ports, a trailblazing leader in … Read more

In the realm of medical innovation, Nuvectis Pharma, Inc. (NASDAQ: NVCT), a trailblazing clinical-stage biopharmaceutical company, embarks on a groundbreaking journey. Their focus? Revolutionizing the … Read more

In a groundbreaking development, Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a visionary player in the field of cancer immunotherapy, has just achieved a significant milestone. The … Read more

BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) — Sensorium Therapeutics (Sensorium), a pioneering biotechnology company that draws inspiration from nature and human experiences to unlock groundbreaking … Read more

In a groundbreaking move, Menarini Asia-Pacific has joined forces with Astellas Pharma Inc., setting the stage for a dynamic partnership aimed at revolutionizing the treatment … Read more

Rome Therapeutics Hits Jackpot: J&J and BMS Join the Investment Party, Boosting Series B Total to $149 Million In a thrilling twist for Boston’s cutting-edge … Read more

Sandoz Strikes Exclusive Deal with Samsung Bioepis for Game-Changing Biosimilar to J&J’s Stelara In a groundbreaking move, Sandoz, a division of Novartis, has inked a … Read more

Acelyrin’s Hidradenitis Suppurativa Drug Misses Mark, but Hope Persists In a rollercoaster ride for Acelyrin, the company revealed top-line data from a Phase IIb/III trial … Read more

2seventy Bio’s Bold Move: CEO Steps Down as Company Slashes Workforce and Refocuses on Profitability In a dramatic shift, 2seventy Bio has initiated a comprehensive … Read more

Alnylam Pharmaceuticals Faces Roadblock in Expanding Patisiran’s Reach for Treating Heart Conditions Alnylam Pharmaceuticals’ ambitious bid to extend the potential uses of its groundbreaking drug, … Read more

Zynex Empowers Shareholders with $10 Million Stock Repurchase Plan ENGLEWOOD, Colo., Sept. 11, 2023 /PRNewswire/ — In a strategic move to fortify its market position, … Read more

Singapore-based Genesis MedTech, a prominent player in the medical device arena, has just scored a remarkable victory with its newly approved absorbable sutures featuring cutting-edge … Read more

In a groundbreaking development, OrthoPediatrics Corp. (NASDAQ: KIDS) has just received the green light from the U.S. Food and Drug Administration (FDA) for its innovative … Read more

This week promises high-stakes decisions in the world of pharmaceuticals, with GSK eagerly anticipating the fate of its myelofibrosis breakthrough, momelotinib. Meanwhile, Alnylam is set … Read more

In a surprising turn of events, FibroGen, which initially showed promise in its Phase II trial, recently dropped a bombshell with the disappointing topline results … Read more

In a groundbreaking move, vaccine giant Moderna and pioneering oncology biotech company Immatics have sealed a transformative research partnership worth over $1.8 billion in potential … Read more

In a groundbreaking announcement, Crinetics Pharmaceuticals revealed that its oral investigational wonder drug, paltusotine, has not only met but exceeded expectations in the Phase III … Read more

In a surprising turn of events, Novartis has decided to part ways with GT005, an eye disease gene therapy, despite its $800 million acquisition of … Read more

In a groundbreaking development, early data from the Phase II EVOKE-02 study has unveiled a potential game-changer in the fight against metastatic non-small cell lung … Read more

In a timely move for the upcoming fall vaccination season, the FDA has given the green light to updated COVID-19 booster shots from Pfizer-BioNTech and … Read more

BioInvent Hits Milestone: Initiates Patient Treatment with Convenient Subcutaneous BI-1206 for Solid Tumors LUND, SE / ACCESSWIRE / September 08, 2023 / In a groundbreaking … Read more

Copenhagen, Denmark, September 8, 2023 – Brace yourself for a transformative event as Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a pioneering biotechnology company dedicated … Read more

La Mesa, CA – September 8, 2023 – Two industry titans, Gold Colloid, Co., a trailblazing point-of-care (POC) test development company, and Claremont BioSolutions LLC, … Read more

Brainomix Pioneers a Revolutionary Partnership with TIPAL Trial to Redefine IPF Treatment OXFORD, UK, September 8, 2023 – Brainomix is set to make medical history … Read more

Sirtex Medical and Magle Group Join Forces to Combat Liver and Lung Cancer Globally WOBURN, Mass., Sept. 8, 2023 /PRNewswire/ — In a landmark collaboration, … Read more

Otsuka and Shape Join Forces in a $1.5 Billion Vision to Revolutionize Ocular Gene Therapies In an electrifying development, Japan’s Otsuka Pharmaceuticals unveiled a transformative … Read more

The Crohn’s disease market in the United States is undergoing a seismic transformation, triggered by the debut of the first Humira (adalimumab) biosimilars in July. … Read more

Seagen and Nurix Unite Forces in $3.4 Billion Quest to Revolutionize Cancer Treatment In a groundbreaking collaboration, Seagen and Nurix Therapeutics are set to rewrite … Read more

Last Week’s Headlines: Pharma Giants Face Off Against Medicare, Illumina’s Leadership Shake-Up, and Surprising Trends in the Life Sciences Workforce Last week witnessed a dramatic … Read more

AstraZeneca’s Alexion division and Verge Genomics Embark on a $840 Million Odyssey to Unearth Rare Disease Miracles with AI In an extraordinary leap forward, AstraZeneca’s … Read more

Unlocking Potential: Syros Pharmaceuticals Empowers New Talent with Rewarding Stock Grants CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a pioneering biopharmaceutical company dedicated to redefining the forefront … Read more

Unlocking New Horizons: Pleco Therapeutics Appoints Dr. Henno Welgemoed as Chief Medical Officer Nijmegen, The Netherlands – 5 September 2023 – In a significant move, … Read more

Hope on the Horizon: Aruna Bio’s Breakthrough Preclinical Results Offer Potential ALS Treatment BOSTON and ATHENS, Ga., Sept. 07, 2023 (GLOBE NEWSWIRE) — Aruna Bio, … Read more

In a groundbreaking initiative, Eli Lilly and Purdue University have rolled out a scholarship program that welcomes its first cohort of 98 students. Their mission? … Read more

Legal Fireworks: Blue Cross and Blue Shield of Louisiana Drops a Bombshell Lawsuit on Bristol Myers Squibb Over Pomalyst In a stunning legal showdown, Blue … Read more

In a surprising twist, Astellas Pharma has chosen to wave the white flag, voluntarily dismissing its legal challenge against the Department of Health and Human … Read more

Alnylam’s Hypertension Breakthrough: Roche Partnership Pays Off in Phase II Triumph In a stunning turn of events, Alnylam Pharmaceuticals is sprinting ahead with its game-changing … Read more

CymaBay Therapeutics Achieves Liver Breakthrough: Seladelpar Hits Bullseye in Phase III Trial In a groundbreaking development, CymaBay Therapeutics announced a stunning victory for its liver … Read more

J&J’s Thrilling Medical Frontier: Opsumit’s Surprising Phase III Halt Shakes Up Pulmonary Hypertension Realm In an unexpected twist, J&J subsidiary Janssen rocked the medical world … Read more

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the global pioneer in scientific advancement, unveils its groundbreaking Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)*, a next-gen Dynabeads … Read more

In a groundbreaking move, OncoNano Medicine, Inc., based in SOUTHLAKE, Texas, has unveiled a pivotal clinical trial supply agreement with none other than Regeneron, heralding … Read more

In a strategic move aimed at pushing the boundaries of cell-based therapeutics, MaxCyte, Inc. (Nasdaq: MXCT; LSE: MXCT), a trailblazing player in cell engineering, has … Read more

California-based BioCardia dropped a bombshell on Tuesday, revealing that its cutting-edge cell therapy, CardiAMP, aimed at combating heart failure, may not achieve its primary goal, … Read more

Despite fierce resistance from pharmaceutical titans and a flurry of lawsuits aimed at thwarting the process, the Centers for Medicare and Medicaid Services (CMS) is … Read more

In the complex world of pharmaceuticals and healthcare, a recent report from the Government Accountability Office (GAO) has unveiled a startling reality: while rebates handed … Read more

On a mission to redefine cancer treatment, Beam Therapeutics marked a major milestone as they administered the first dose of BEAM-201 to a courageous patient. … Read more

Moderna Unveils Game-Changing Update: COVID-19 Vaccine Packs a Punch Against New Variants! In a groundbreaking development, Moderna has revealed that its latest vaccine iteration is … Read more

Nimbus Therapeutics is making waves in 2023 with a whopping $210 million cash infusion to drive its cutting-edge small-molecule medicine research. This funding surge is … Read more

In a surprising twist, the FDA has slammed the brakes on AstraZeneca’s ambitious plans to expand the horizons of its revolutionary drug, Ultomiris (ravulizumab-cwvz). The … Read more

Olema Oncology Gains Impressive $180 Million Boost in Combined Financing SAN FRANCISCO, Sept. 05, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: … Read more

Alteogen’s Tergase® Breaks Ground with Zero Immunogenicity in Clinical Triumph DAEJEON, South Korea, September 5, 2023 – Brace yourselves for a medical marvel! Alteogen Inc. … Read more

San Diego, September 5, 2023 – Inmagene Biopharmaceuticals, a trailblazing clinical-stage biotech firm dedicated to pioneering therapies for immunological and inflammatory diseases, has just scored … Read more

Crossject Achieves Manufacturing Milestones: Gains ISO Certifications, FDA Audit Readiness, and ANSM Authorization Dijon, France, September 5, 2023 – Crossject (ISIN: FR0011716265; Euronext: ALCJ), the … Read more

HANGZHOU and SHAOXING, China, Sept. 4, 2023 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) is set to make waves as it steps onto the … Read more

SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies, Inc. (NYSE: A) has just unveiled an exciting new chapter in its leadership team with the appointment of Philip … Read more

“Novartis Takes a Stand: Files Lawsuit Against Health Department Over Drug Price Negotiation Program” In a bold move, Novartis has entered the legal fray by … Read more

In a significant development, Genmab and Seagen have unveiled interim data from the Phase III innovaTV 301 trial, showcasing the remarkable potential of their antibody-drug … Read more

In a strategic move that’s been eagerly anticipated, Novartis has officially given the green light to the spin-off of its generics and biosimilars powerhouse, Sandoz. … Read more

After months of corporate turbulence and high-stakes battles, Illumina has placed its bets on a new leader, Jacob Thaysen, who will step into the role … Read more

Breaking Barriers in Swine Health: Novozymes and Bactolife Forge a Powerful Alliance to Tackle Post-Weaning Diarrhea in Piglets and Transform the Antibiotic Landscape! Copenhagen, Denmark … Read more

Before groundbreaking therapies for Alzheimer’s disease gained approval, the concept of biomarker tests remained on the periphery. However, a new dawn is breaking in the … Read more

In the dynamic realm of biopharma, GLP-1 receptor agonists are blazing a trail. Originally designed to combat type 2 diabetes and obesity, these remarkable drugs … Read more

Breaking Barriers in Disease Treatment: RLYB116’s Remarkable Journey NEW HAVEN, Conn.–(BUSINESS WIRE)– Rallybio Corporation (Nasdaq: RLYB), a trailblazing biotech firm dedicated to transforming the lives … Read more

Medivir Breaks New Ground: First Complete Response in Phase 1b HCC Study with Fostrox and Lenvima STOCKHOLM, Sept. 4, 2023 /PRNewswire/ — Medivir AB (Nasdaq … Read more

LUND, Sweden, Sept. 4, 2023 /PRNewswire/ — Oncorena, the vanguard of medical innovation, is thrilled to announce a remarkable milestone—the first patient has received treatment … Read more

STOCKHOLM, Sept. 4, 2023 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a pioneering developer of augmented intelligence-based solutions for skin disorders, is thrilled to … Read more

SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has taken a bold step towards embracing fresh talent. On September 1, 2023, the Human Capital Management … Read more

Championing Unsung Heroes of Healthcare: Fresenius Kabi and AABB Illuminate the 18th Annual Blood Collectors Week, September 3-9, 2023 LAKE ZURICH, Ill. & BETHESDA, Md.–(BUSINESS … Read more

Breaking Boundaries in Cancer Care: ICPO Foundation and NTP Radioisotopes SOC Ltd. Join Hands for a Transformative Collaboration In a groundbreaking announcement from WIESBADEN, Germany, … Read more

Breaking Barriers: IQVIA’s Visionary Leader, Ari Bousbib, Takes the Stage at the Morgan Stanley Annual Global Healthcare Conference in New York City! RESEARCH TRIANGLE PARK, … Read more

PHILADELPHIA, Sept. 01, 2023 (GLOBE NEWSWIRE) – Get ready to be inspired as Amicus Therapeutics, Inc. (Nasdaq: FOLD) makes its mark on the global healthcare … Read more

PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) – Get ready to dive into the future of healthcare with Integra LifeSciences Holdings Corporation (NASDAQ: IART), a … Read more

“Empowering Visionaries: MustGrow Rewards Trailblazers with RSUs and DSUs” Saskatoon, Saskatchewan – September 1, 2023 – MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0), … Read more

GENEVA, SWITZERLAND / ACCESSWIRE / September 1, 2023- Get ready for a dose of innovation and vision as Relief Therapeutics Holding SA (SIX: RLF) (OTCQB: … Read more

“Kiora Pharmaceuticals: Shaping the Future with Your Vote – Special Meeting Rescheduled to September 27!” Encinitas, California – September 1, 2023 – Kiora Pharmaceuticals, Inc. … Read more

Meet the Newest Star on Mölnlycke’s Board: Leslie McDonnell Takes the Helm” GOTHENBURG, Sweden, Sept. 1, 2023 – Mölnlycke AB welcomes a dynamic addition to … Read more

Breaking News from Madison, Wisconsin! Exact Sciences Corp. (Nasdaq: EXAS), the trailblazing leader in cancer screening and diagnostic tests, is gearing up for an electrifying … Read more

Exciting News from Silver Spring, MD, and Research Triangle Park, NC! United Therapeutics Corporation (Nasdaq: UTHR), a dynamic public benefit corporation, is set to make … Read more

In a groundbreaking announcement from Lund, Sweden, on September 1, 2023, Hansa Biopharma, also known as ‘Hansa’ on the Nasdaq Stockholm under the symbol HNSA, … Read more

Palo Alto, CA – Guardant Health Inc. (Nasdaq: GH), pioneers in precision oncology, has unveiled a bold statement regarding the conclusion of the COBRA study, … Read more

Globus Medical and NuVasive: A Game-Changing Merger for Musculoskeletal Innovation In a landmark move, Globus Medical, Inc. (NYSE: GMED), a trailblazing musculoskeletal solutions company, has … Read more

Unlocking the Mystery of IPF: A Breathless Journey into the Enigmatic World of Idiopathic Pulmonary Fibrosis (IPF) LA JOLLA, CA / ACCESSWIRE / September 1, … Read more

Hugel’s Grand Comeback: Letybo Botulinum Toxin Aims for FDA Approval in Q1 2024 SEOUL, South Korea, Sept. 1, 2023 /PRNewswire/ — Hugel, the global leader … Read more

Senators Demand Clarity: Lilly, Novo Nordisk, and Sanofi Under Scrutiny for Insulin Assistance Programs In a quest for transparency, U.S. Senators Maggie Hassan and Tina … Read more

BioNTech’s Bold Move: ADC Gears Up for Phase III Battle in Breast Cancer Arena In a strategic move to challenge industry giants like AstraZeneca and … Read more

Alvotech’s Brave Bid for FDA Recognition: AVT02’s Quest for Biosimilar Glory In a bold move, Alvotech has resubmitted its Biologics License Application to the FDA, … Read more

Bavarian Nordic Abandons COVID Booster as New Variants Steal the Spotlight In a dramatic turn of events, Danish company Bavarian Nordic is bowing out of … Read more

2022’s Biggest Biotech Showdown: Amgen-Horizon Deal Gets FTC’s Nod In a thrilling twist, the Federal Trade Commission (FTC) has given the green light to the … Read more

In a whirlwind week of regulatory developments, the stage was set for high-stakes battles in the pharmaceutical world. On Friday, the Federal Trade Commission granted … Read more

“Empowering Change: Cleveland Diagnostics’ Dynamic Prostate Cancer Campaign Puts ‘A PSA on PSA’” CLEVELAND, August 30, 2023— Brace for impact as Cleveland Diagnostics, the vanguard … Read more

CARLSBAD, Calif., Aug. 30, 2023 /PRNewswire/ — Igniting Insights: Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) is Set to Ignite Investor Conversations at Prestigious September 2023 Conferences … Read more

BOSTON, Aug. 30, 2023 /PRNewswire/ — Brace yourselves for an electrifying convergence of innovation! Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”), the architect of an … Read more

“Rivalry of Titans: Pfizer and BioNTech Throw Down the Gauntlet, Challenging Moderna’s COVID-19 Patents” In a gripping showdown that could reshape the landscape of COVID-19 … Read more

“FibroGen’s Bumpy Ride Continues: Setback in Phase III DMD Trial Sends Stocks Tumbling” In a disheartening blow, FibroGen unveiled disappointing results on Tuesday, revealing that … Read more

“FDA Delivers Stunning Blow: Outlook’s Ambitious Quest for Wet AMD Treatment Thwarted, Shares Plummet” In a surprising turn of events, the FDA cast a shadow … Read more

Amidst the sizzling momentum of the obesity market, Novo Nordisk is making strategic waves yet again. In a bold move announced on Wednesday, the Danish … Read more

“Unlocking the Future: Navigating the Skills Gap in Cell and Gene Therapies” Step into the realm of cell and gene therapies, a realm ablaze with … Read more

Navigating the labyrinth of cause and effect to show a young mind how present choices intertwine with the future is a boundless challenge. For Franz-Werner … Read more

Venturing into new technological territories is often met with the challenge of uncertain regulations, and this holds particularly true for early adopters. In the dynamic … Read more

“Unlocking the Future of Cell Therapies: Celularity Teams Up with Regeneron in Groundbreaking Research Partnership FLORHAM PARK, N.J., Aug. 29, 2023 (GLOBE NEWSWIRE) — Brace … Read more

SHANGHAI, Aug. 29, 2023 /PRNewswire/ — Setting the Stage for Progress: Fosun Pharma’s Thrilling 2023 Interim Results Unveiled! On August 29, 2023, Shanghai Fosun Pharmaceutical … Read more

Major Breakthrough: Zealand Pharma’s Dasiglucagon Gains Priority Review by US FDA for Innovative Treatment of Congenital Hyperinsulinism Copenhagen, Denmark, August 30, 2023 – Zealand Pharma … Read more

SHANGHAI, Aug. 30, 2023 /PRNewswire/ — Get ready for a groundbreaking stride in the realm of medical progress as Asieris Pharmaceuticals (688176), a global biopharma … Read more

Breaking Boundaries in Cancer Treatment: A Glimpse into BioInvent’s Triumphs LUND, SWEDEN / ACCESSWIRE / August 30, 2023 / Brace for Impact: BioInvent International (STO:BINV) … Read more

Unleashing Triumph: Akeso’s 2023 Interim Results Soar with Phenomenal Growth HONG KONG, Aug. 29, 2023 /PRNewswire/ — Brace for Impact: Akeso (9926. HK) is rewriting … Read more

NANJING, China, Aug. 29, 2023 /PRNewswire/ — Brace for Impact: InxMed, a beacon of innovation in the biotech arena, is making waves yet again. Focused … Read more

Breaking Ground in Healthcare Innovation: SHENZHEN, China, Aug. 29, 2023 — Mark your calendars as Mindray (SZSE: 300760), a vanguard in cutting-edge medical solutions, proudly … Read more

Unlocking Boundless Potential: Join us on an Exciting Journey with argenx in Amsterdam, the Netherlands (Euronext & Nasdaq: ARGX). Brace yourself for a remarkable September … Read more

Unleashing the Future of Research: BioSkryb Genomics and Everlife-RI Join Forces to Illuminate Southeast Asia with Cutting-Edge Single-Cell Multiomics Solutions DURHAM, N.C.–(BUSINESS WIRE)– In a … Read more

Breaking Frontiers: ALE.F02’s Intriguing Quest to Transform Pulmonary Fibrosis Treatment BASEL, Switzerland–(BUSINESS WIRE)– Brace yourself for a revelation that could reshape medical history! Alentis Therapeutics, … Read more

Visionary Moves: Bausch + Lomb’s CEO Brent Saunders Takes Center Stage at the 2023 Wells Fargo Healthcare Conference VAUGHAN, Ontario–(BUSINESS WIRE)– Get ready for a … Read more

“Unleashing Innovation: DZD Scores Major Win for Safer Fecal Microbiota Transplants with SBIR Funding BOSTON, Aug. 29, 2023 /PRNewswire/ — Brace yourself for a game-changing … Read more

“Catalent Unveils Strategic Evolution: New Board Appointments, Transformational Initiatives, and a Vision for Long-Term Value” SOMERSET, N.J.–(BUSINESS WIRE)– The stage is set for transformation as … Read more

“Unveiling a Health Revolution: Eli Lilly’s Bold Leap with Cholesterol-Busting Pill, Muvalaplin, in Groundbreaking Phase I Trial” In the world of medical exploration, where breakthroughs … Read more

“Whispers of Promise Meet Unexpected Turn: Novocure’s Ovarian Cancer Journey Takes an Unexpected Twist in Phase III INNOVATE-3 Trial” In the high-stakes world of medical … Read more

“Charting a Bold Course: BMS Expands Reblozyl’s Arsenal with FDA’s Stamp of Approval” Bristol Myers Squibb is on a resolute march toward its grand vision … Read more

“Medicare’s Pharmaceutic Showdown: The First 10 Prescription Mavericks Stepping into the Ring of Price Negotiation” In a theatrical twist that has the pharmaceutical world buzzing, … Read more

I might be revealing a touch of my age, but I’ve weathered the storm through four jaw-dropping microcap meltdowns: the tumultuous dance of 1987, the … Read more

July reached its crescendo with a surprising twist as Lupin Pharmaceuticals, a major player in the drug production saga, issued yet another recall. This time, … Read more

Mark Your Calendar: Join the Buzz with Axonics at September’s Exciting Investor Conferences! IRVINE, Calif.–(BUSINESS WIRE)– Get ready to dive into the world of cutting-edge … Read more

In a groundbreaking stride towards transparency, the Plasma Protein Therapeutics Association (PPTA) has unveiled its latest research revelation. This study, a meticulously conducted investigation titled … Read more

Unveiling the Enigmatic Y Chromosome: A Leap in Understanding Human Evolution and Biology FARMINGTON, Conn., Aug. 24, 2023 /PRNewswire/ — A cryptic treasure trove of … Read more

“Unveiling a New Era of Pain Relief: Medtronic’s Inceptiv™ SCS Revolutionizes Therapy with Innovative Closed-Loop Technology” Dublin, August 25, 2023—A groundbreaking chapter in pain management … Read more

“Unexpected Triumph: Exelixis Breaks Convention, Halts Phase III CABINET Trial Early Due to Stunning Progress” In a stunning twist that sent ripples through the scientific … Read more

“Unveiling the Blueprint for the UK’s Journey to Scientific Supremacy: A Tale of Infrastructure and Expertise” In the wake of August’s leadership elections, a resounding … Read more

“Breaking Barriers: FDA Greenlights Sandoz’s Tyruko, a Game-Changing Biosimilar to Biogen’s Tysabri” In a watershed moment for medical progress, the FDA has handed down a … Read more

“Novo Nordisk Unveils Yet Another Triumph: Wegovy’s Heart-Boosting Power Extends to Common Heart Failure” In a resounding symphony of medical achievement, Novo Nordisk, the Danish … Read more

In the ever-evolving landscape of medical breakthroughs, few phrases carry as much weight as ‘wonder drug.’ Novo Nordisk’s Wegovy (semaglutide) is dancing dangerously close to … Read more

“Collaborative Drug Quest Takes a Turn: Keytruda and Lenvima Combination Trial Dropped Following Phase III Disappointment” In a maze of medical exploration, two pharmaceutical trailblazers, … Read more

“Recce Pharmaceuticals Achieves Major Milestone: Administers First Doses in Game-Changing Clinical Trial of RECCE® 327, a Potential Revolution for Diabetic Foot Infections” SYDNEY, Australia, Aug. … Read more

“Revolutionizing Diabetes Treatment: Abata Therapeutics Unveils ABA-201, a Groundbreaking Treg Cell Therapy for Type 1 Diabetes WATERTOWN, Mass.–(BUSINESS WIRE)–In a landmark breakthrough, Abata Therapeutics is … Read more

“Game-Changer Alert: AEON Biopharma Secures Vital Patent for Breakthrough Migraine Treatment” IRVINE, Calif., Aug. 24, 2023 – Brace yourselves for a groundbreaking moment in medical … Read more

“Unlocking Insights: Rune Labs and Aspen Neuroscience Unite to Pioneer Breakthrough Parkinson’s Research” SAN FRANCISCO—In a remarkable convergence of innovation, Rune Labs and Aspen Neuroscience … Read more

“Unleashing Breakthroughs: Xcell Biosciences and Labcorp’s Dynamic Partnership Elevates Cell and Gene Therapy Frontiers” SAN FRANCISCO—In a symphony of scientific innovation, Xcell Biosciences Inc. (Xcellbio) … Read more

SHANGHAI, Aug. 24, 2023 /PRNewswire/ — Embarking on a Pioneering Journey: Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), a trailblazing biopharmaceutical powerhouse, has unveiled … Read more

SILVER SPRING, Md., Aug. 24, 2023 /PRNewswire/ — A Remarkable Leap Forward: Today, the U.S. Food and Drug Administration has granted its seal of approval … Read more

“Plot Twist: AbbVie Shakes Up Strategy, Bids Farewell to Two Cutting-Edge Cancer Ventures” In a surprising turn of events, AbbVie has set the stage for … Read more

“Unleashing Hope: Roche’s Divarasib Shines in Battle Against Stubborn KRAS-Mutated Solid Tumors” In a thrilling revelation, Roche’s Genentech has unveiled a potential game-changer in the … Read more

“Swiss Marvel: Ferring Pharmaceuticals Surges as Royalty Pharma Invests a Staggering $500 Million in Revolutionary Gene Therapy” In a groundbreaking move, Ferring Pharmaceuticals, based in … Read more

“From Leiden to the World: Pharming Group Gears Up for a Transatlantic Conference Spree!” LEIDEN, The Netherlands, Aug. 24, 2023 /PRNewswire/ — Brace yourselves for … Read more

“Unveiling a Maverick’s Odyssey: CancerVAX CEO Dives Deep into Conversation with UCLA’s Trailblazing Cancer Crusader, Dr. Steven Jonas” LEHI, Utah, Aug. 24, 2023 (GLOBE NEWSWIRE) … Read more

“A Bold Leap Towards Conquering Leukemia: XNK Therapeutics Joins Hands with Karolinska University Hospital to Pioneer Breakthrough Research!” HUDDINGE, Sweden, Aug. 24, 2023 /PRNewswire/ — … Read more

“San Diego, CA – August 24, 2023 – A New Dawn in Diagnostics: Gold Colloid, Co. Emerges as a Trailblazer in Rapid Immunodiagnostic Lateral Flow … Read more

“J&J Initiates Strategic Shift: Infectious Disease and Vaccine Unit Undergoes Transformation” In a strategic maneuver that’s capturing industry attention, Johnson & Johnson is orchestrating a … Read more

“Revolutionizing Healthcare: CVS Health Unveils Cordavis, its Biosimilars Marvel” A seismic shift has erupted in the realm of consumer healthcare, as CVS Health steps onto … Read more

In the ever-evolving realm of biotechnology, where breakthroughs are a daily currency, an unexpected blind spot has emerged: the realm of employer branding. While the … Read more

From his formative years in Lebanon, where he once led his childhood soccer squad, Bob Dagher’s passion for teamwork found an unexpected echo in his … Read more

Breaking Boundaries: Vaxxas Joins Forces with Wellcome and SK Bioscience to Supercharge Typhoid Vaccination! In a groundbreaking collaboration, Vaxxas, the trailblazing biotech company behind an … Read more

Exciting Partnership Unleashed: Royalty Pharma’s $500 Million Boost for Ferring’s Breakthrough Bladder Cancer Therapy! In a groundbreaking collaboration, Royalty Pharma and Ferring Pharmaceuticals have ignited … Read more

Spark of Excitement: Atrion Corporation Amps Up Quarterly Cash Dividend to $2.20 Per Share – August 22, 2023 ALLEN, Texas—In a resounding declaration of value … Read more

In an exciting move, Coherus BioSciences, headquartered in REDWOOD CITY, Calif., made a significant announcement on August 22, 2023. The innovative biotech company (Nasdaq: CHRS) … Read more

Unleashing Agility: Kinaxis® Powers Italian Pharmaceutical Trailblazer to Conquer Market Turbulence OTTAWA, Ontario–(BUSINESS WIRE)– In a symphony of innovation, Kinaxis® Inc. (TSX: KXS), the maestro … Read more

Embracing over a decade of groundbreaking Innovation by Design, the spotlight of 2023 falls on exceptional endeavors from industry giants like Adobe, PepsiCo, and Canva, … Read more

Unleashing Innovation: Foundery Sparks a Biotech Revolution, Linking Visionary Drug Development with Immune Discoveries SAN FRANCISCO, Aug. 22, 2023 (GLOBE NEWSWIRE) — Brace yourselves for … Read more

A New Era Dawns: Grander’s Bold Leap Transforms into PolarityTE’s Private Vanguard SALT LAKE CITY, Aug. 22, 2023 /PRNewswire/ — Amidst a symphony of anticipation, … Read more

Exciting Update from Longeveron: Embarking on a Journey to Transform Lives! MIAMI, Aug. 22, 2023 (GLOBE NEWSWIRE) — Brace yourselves for groundbreaking news from Longeveron … Read more

“SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) — Brace for Impact: Myriad Genetics, the Vanguard of Genetic Exploration, and Onsite Women’s Health, Champions of … Read more

“Revolution Unleashed: ANT Triumphs with 10 Brave Hearts Leading the Charge in Breakthrough Trial!” LOS GATOS, Calif., Aug. 22, 2023 /PRNewswire/ — Brace yourselves for … Read more

OREM, Utah, Aug. 22, 2023 (GLOBE NEWSWIRE) — Brace yourselves for a frozen revolution as Reflect Scientific, Inc. (Symbol: RSCF), the reigning maestro of cutting-edge … Read more

“Unlocking the Future of Pediatric Growth: Join the Virtual Webinar on September 5, 2023, at 11:00 AM Eastern Time!” AUSTIN, Texas, Aug. 22, 2023 (GLOBE … Read more

Boehringer Ingelheim has thrown down the gauntlet against the U.S. government, unleashing a legal battle to halt the Inflation Reduction Act’s drug price negotiation program. … Read more

“Breaking Boundaries: FDA Greenlights Pfizer’s Revolutionary Maternal RSV Vaccine, Shielding Infants” In a remarkable stride forward, the FDA has granted approval to Pfizer’s groundbreaking Abrysvo … Read more

“Unmasking the Ties: Industry Influence Raises Alarms in Leading Patient Advocacy Organizations” A revealing spotlight has been cast upon the inner workings of top U.S. … Read more

Unlocking Hope: Fulcrum’s Sickle-Cell Breakthrough Surges Forward as FDA Lifts Clinical Hold The tides of progress are in favor of Fulcrum Therapeutics as they charge … Read more

“Teva Pharmaceuticals Strikes a Legal Chord: Navigating the Labyrinth of Drug Price-Fixing Case” In a legal symphony that reverberates through the pharmaceutical world, Teva Pharmaceuticals … Read more

“Novavax’s Swift Reckoning: Defying Odds, Tackling Subvariants, and Forging Ahead with a Season of Hope” In the realm of COVID-19 battles, Novavax stands as a … Read more

Eli Lilly Emerges Victorious in a Thrilling Showdown Against Thyroid Cancer: Retevmo Takes the Lead in High-Stakes RET-Mutant Battle In an electrifying twist within the … Read more

A Breakthrough Emerges: Recor Medical and Otsuka Medical Devices Secure FDA Panel’s Favor for Paradisiacal Hypertension Solution PALO ALTO, Calif.–(BUSINESS WIRE): Brace yourselves for a … Read more

London, UK – August 22, 2023: Brace yourself for the remarkable tale of Actimed Therapeutics Ltd (“Actimed”), a UK-based trailblazer in the world of clinical … Read more

Whispers of Innovation: A Symphony from Zurich’s Heart ZUG, Switzerland, August 22, 2023 /PRNewswire/ — Amidst the Echoing Chimes of Swiss Precision, Berlin Heals Holding … Read more

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in the realm of targeted radiotherapies, has illuminated the spotlight with its latest announcement. Set against the … Read more

Diving into Innovation: Frank Gleeson, the Visionary CEO of Satellos Bioscine (TSXV: MSCL), Illuminates the Company’s Journey in a Captivating Conversation with TMX Group Unlocking … Read more

Unveiling the Puzzle: Breakthrough Insights from Integra Connect Illuminate the Path to Precision Cancer Care WEST PALM BEACH, Fla., Aug. 21, 2023 /PRNewswire/ — Brace … Read more

Unveiling Triumphs from the Heart of Princeton: Soligenix’s Remarkable Journey and Q2 2023 Financial Feats PRINCETON, N.J., August 21, 2023 /PRNewswire/ – Brace yourself for … Read more

“From Coast to Coast, a Visionary Voyage: Mark C. McKenna Anchors Apogee Therapeutics, Steering the Ship of Innovation” SAN FRANCISCO and WALTHAM, Mass., Aug. 21, … Read more

The exciting journey of discovery unfolded through a meticulously designed randomized, double-blind, controlled trial. This trailblazing effort successfully reached its primary endpoint, showcasing a remarkable … Read more

“In a Stunning Leap, AI Breaks Ground in Enzyme Revolution, Sparking a New Era of Bioproduction” NESS ZIONA, Israel, Aug. 21, 2023 /PRNewswire/ — Enzymit, … Read more

A Symphony of Progress: Amicus Therapeutics Welcomes Financial Maestro Simon Harford In a dynamic crescendo that reverberated across the biotech landscape, Amicus Therapeutics, Inc. (Nasdaq: … Read more

Revolutionizing Gene Editing: A Symphony of Innovation Unveiled by Promega Scientists Sparks New Era of Precision. MADISON, Wis.–(BUSINESS WIRE)– In a riveting chapter of scientific … Read more

Unveiling a New Era: ALACHUA, Fla. and TAMPA, Fla., Aug. 21, 2023. Amid a symphony of innovation and commitment, Axogen, Inc. (NASDAQ: AXGN), a trailblazer … Read more

PITTSBURGH, Aug. 21, 2023 (GLOBE NEWSWIRE) — Brace yourself for a groundbreaking announcement from Krystal Biotech Inc. (NASDAQ: KRYS), a trailblazing biotech powerhouse on a … Read more

Unveiling Genomic Insights: GeneDx Sparks Transformation in Genetic Diagnosis STAMFORD, Conn., Aug. 21, 2023 — In a groundbreaking stride towards deciphering the genetic enigma, GeneDx … Read more

PONTE VEDRA’s New Maestro of Innovation: Treace Medical Concepts Welcomes Nathan Minnich as Sr. Vice President, Unleashing a New Era of Surgical Excellence PONTE VEDRA, … Read more

Seoul’s MedTech Trailblazer, Apollon, Partners with MIT to Forge the Future of Non-Invasive Glucose Monitoring SEOUL, South Korea — In a daring fusion of minds … Read more

Breaking New Horizons: Enveric Biosciences (NASDAQ: ENVB) Ushers in a New Era of Healing in CAMBRIDGE, Mass. A Symphony of Innovation and Dedication Unveiled! Enveric … Read more

Turning the Tide: Geron’s Imetelstat Breakthrough Clears FDA Hurdle, Paving the Way for Innovative Treatment of Myelodysplastic Syndromes FOSTER CITY, Calif.–(BUSINESS WIRE)– The stage is … Read more

Fusion of Innovation: Moderna Joins Forces with CARsgen Therapeutics to Forge a Powerful Duo Against Solid Tumor Cancers In an electrifying collaboration, Moderna and China’s … Read more

Dramatic Twist: FDA Places Gilead’s Breakthrough Leukemia Drug, Magrolimab, on Clinical Hold Again In a surprising turn of events, the FDA has thrown another curveball … Read more

A Triumph of Science: Breaking Barriers in Cancer Research as CanariaBio’s Innovator, MAb-AR20.5, Achieves Landmark Orphan Drug Designation for Pancreatic Cancer PYEONGTAEK, South Korea, Aug. … Read more

WARREN, NJ, Aug. 21, 2023 (GLOBE NEWSWIRE) — through the Vibrant Pulse of NewMediaWire — Brace yourselves for a groundbreaking alliance as Timber Pharmaceuticals, Inc. … Read more

“FLORHAM PARK, N.J., Aug. 21, 2023 (GLOBE NEWSWIRE) — Brace yourselves for groundbreaking news as Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a trailblazing biopharmaceutical powerhouse, strides … Read more

In the vibrant city of Gainesville, where innovation knows no limits, a symphony of progress echoes. Hear the crescendo as Exactech, Inc. takes center stage … Read more

SAN DIEGO–(BUSINESS WIRE)–In a leap towards scientific advancement, Scale Biosciences, Inc. (aka ScaleBio), a trailblazer in single-cell sequencing technology, has unveiled an exciting partnership with … Read more

Introducing a Revolution in Aesthetics: Transformative Care for the Delicate Eye Area PARK CITY, Utah, Aug. 21, 2023 /PRNewswire/ — Brace yourselves for a groundbreaking … Read more

Embarking on a Trail of Innovation: Shlomi Nachman Joins Expanse Medical’s Board of Visionaries PLEASANTON, Calif., Aug. 21, 2023 /PRNewswire/ — Expanse Medical, the trailblazing … Read more

In the heart of HOLLISTON, a tale of innovation unfolds on August 21, 2023. Enter Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN), a protagonist in … Read more

From the vibrant city of HAIFA, Israel, a groundbreaking saga unfolds on August 21, 2023. In a crescendo that resonates across borders, the stage belongs … Read more

At the forefront of scientific marvels stands CRISPR-Cas9, the very essence of gene-editing wizardry that earned Jennifer Doudna and Emmanuelle Charpentier the crown of Nobel … Read more

In a game-changing move, the FDA has bestowed a new chapter upon Regeneron’s vision-transforming masterpiece, Eylea (aflibercept). A crescendo of innovation resonates as the label’s … Read more

In a groundbreaking twist, the powerful duo of Roche’s Tecentriq (atezolizumab) and Exelixis’ Cabometyx (cabozantinib) has triumphed on a crucial battlefield. The pivotal Phase III … Read more

Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies, is excited to announce its participation in the Baird 2023 Global Healthcare Conference. … Read more

Embarking on a Journey of Innovation: SILVER SPRING, Md., Aug. 18, 2023 /PRNewswire/ — Brace yourselves for a riveting revelation as the U.S. Food and … Read more

Ultragenyx Pharmaceutical Inc., a visionary biopharmaceutical firm committed to revolutionizing treatments for rare and ultra-rare ailments, has just unveiled an exciting development. In a bold … Read more

In a burst of exciting developments on August 18, 2023, SAN CARLOS-based powerhouse Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) unveiled its game-changing strides in the fight … Read more

With the tenacious energy of a decade-long journey, these options offer an exciting path forward, each bearing an exercise price of $4.65 per share, mirroring … Read more

TORONTO, Aug. 18, 2023 /CNW/ – A Ray of Hope Pierces the Horizon: Mitsubishi Tanabe Pharma Canada (MTP-CA), a Proud Offspring of Mitsubishi Tanabe Pharma … Read more

A Symphony of Defense Unveiled: Moderna Takes the Stage on Thursday, Revealing a Marvelous Revelation. Their Upgraded COVID-19 Warriors Rise, Crafting Shields of Neutralizing Antibodies … Read more

Defying the Shadows of Rare Liver Disease: Genethon’s Brave Journey into Gene Therapy Illuminates Hope for Crigler-Najjar Syndrome, as Promising Phase I/II Findings Grace the … Read more

A Curtain Call for Change: Kodiak Sciences’ Visionary Jason Ehrlich Bids Farewell as Chief Medical Officer and Chief Development Officer. The Countdown Begins as his … Read more

In a Thrilling Update, Merck’s Welireg (belzutifan) Smashes Expectations in Phase III LITESPARK-005 Trial. A Remarkable Leap Forward as Patients Battling Advanced Renal Cell Carcinoma … Read more

Igniting the Flames of the Weight-Loss Arena: Boehringer Ingelheim Emerges as the Trailblazer, Unveiling a Grand Plan for the Promising Obesity Drug Hope, Survodutide. In … Read more

A Historic Triumph: FDA’s Seal of Approval Graces Regeneron’s Veopoz, a Pioneer in CHAPLE Disease Battle—A Name Echoed by the Whispers of CD55-Deficient Protein-Losing Enteropathy. … Read more

Shanghai, August 20, 2023 – In a Thrilling Symphony of Progress, Everest Medicines (HKEX 1952.HK) Takes Center Stage: The Grand News Unveiled – FDA’s Embrace … Read more

Emerging from the August’s Political Forge, a Resounding Pledge Echoes: Transform the UK into a ‘Scientific Superpower’, A Beacon of Opportunity Illuminating Every Nook. A … Read more

Embarking on a Bold Experiment, the FDA Initiates a Voluntary Pilot Program to Tackle the Unseen Perils of Greenlighting Precise Cancer Therapies Without Their Trusty … Read more

Steering Toward Breakthroughs: CRISPR-Cas9, the Nobel Prize-Winning Genetic Marvel by Jennifer Doudna and Emmanuelle Charpentier, Nears its Debut in Alzheimer’s Clinical Trials. Yet, Amidst the … Read more

Embarking on a Quest of Discovery, Unveiling from YONGIN, South Korea, Aug. 17, 2023 /PRNewswire/ — Brace yourselves for a groundbreaking revelation from the heart … Read more

Thrilling Financial Venture Unfolds in Cleveland! In an electrifying move, Athersys, Inc. (Nasdaq: ATHX) has just unveiled its captivating “reasonable best efforts” public offering. Brace … Read more

Unveiling the Heat-Defying Marvel: Procaps Group Revolutionizes Gummies for a Seamless Journey MIAMI & BARRANQUILLA, Colombia–(BUSINESS WIRE) — Brace yourself for a game-changer in the … Read more

TUCSON, Ariz., Aug. 16, 2023 (GLOBE NEWSWIRE) — Sparks fly as the battleground over education equity intensifies. In a razor-thin vote of 6 to 5 … Read more

PLYMOUTH MEETING, Pa., Aug. 16, 2023 /PRNewswire/ — The National Comprehensive Cancer Network® (NCCN®), a dynamic alliance of leading cancer centers, proudly unveils a wealth … Read more

Unlocking Unity and Success: The Power of Employee Resource Groups (ERGs) in Shaping Inclusive Workplaces. Discover how ERGs Drive Engagement, Retention, Recruitment, and Business Goals, … Read more

FDA Greenlights Delcath Systems’ Hepzato Kit for Cutting-Edge Liver-Directed Treatment of Metastatic Uveal Melanoma, Culminating a Ten-Year Odyssey to Regulatory Approval Hepzato’s Unveiled Realm: Illuminating … Read more

Intrigue Unveiled: Stada’s $11 Billion Puzzle of Possibility! Amidst the whispers of change, the stage is set for a monumental decision. Imagine a world where … Read more

Plot Twist in Medical Saga: FDA Skips the Spotlight on bluebird bio’s Revolutionary Lovo-Cel Gene Therapy for Sickle Cell Disease! A Thrilling Quest: Lovo-Cel’s Destiny … Read more

Unlocking New Avenues in Cancer Battle: Brace yourself for a breakthrough unveiled by the biotech visionary, Seagen! With Wednesday’s dawn came a symphony of hope … Read more

Up to an additional $100 million made available in two tranches Fueling Innovation from Saint-Herblain, France, August 17, 2023: Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a … Read more

Innovative Leap in Lab Tech! Roche’s Latest Breakthrough Unveiled in Basel, Switzerland — Introducing CCM Vertical, the Future of Sample Transportation. Say Goodbye to Conventional … Read more

BOULDER, CO / ACCESSWIRE / August 15, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a pioneering force in global healthcare, harnessing the power of patented Microcyn® … Read more

MELBOURNE, Australia–(BUSINESS WIRE)– Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a pioneering biopharmaceutical powerhouse on a mission to revolutionize cancer treatment, has … Read more

ALPHARETTA, Ga., Aug. 15, 2023 /PRNewswire/ — Medicus IT, a pioneering force in healthcare technology solutions, is thrilled to unveil the arrival of Emily Sorrick … Read more

TAMPA, Fla., Aug. 15, 2023 /PRNewswire/ — Igniting a Green Revolution, The Mosaic Company (NYSE:MOS) has unveiled the groundbreaking Mosaic Biosciences™ platform. This global initiative … Read more

Harmony Biosciences Makes Bold Move, Aims to Transform Portfolio: Enters Acquisition Talks with Zynerba Pharmaceuticals for Expansion into Rare Neuropsychiatric Disorders In a Strategic Move, … Read more

Design Therapeutics Encounters a Twist in the Journey as Phase I Friedreich’s Ataxia Drug Hits a Bumpy Road with Injection Site Reactions. In a Strategic … Read more

Arcellx’s Triumph: Rekindling Hope for Multiple Myeloma Warriors. Against the Odds, iMMagine-1’s Phase II Journey Ignites Anew. Like a Phoenix Rising, FDA’s Greenlight Reignites Arcellx’s … Read more

The GALACTIC-1 Chronicles: Galecto’s Bold Journey Meets a Surprising Twist. Amid the Quest to Defy Fate, GB0139 Steps Forward as the Hopeful Hero. But Alas, … Read more

FDA’s Green Light: Pfizer’s Game-Changing Bispecific, Elrexfio, Rockets Forward with Accelerated Approval to Combat Relapsed or Refractory Multiple Myeloma! Empowering Hope: Elrexfio’s Breakthrough Label Embraces … Read more

Unveiling AN2 Therapeutics’ Triumph: A Bold Step Forward! From the Heart of Silicon Valley Emerges a Powerhouse, AN2 Therapeutics, Inc. (Nasdaq: ANTX). Guided by the … Read more

Crossing Borders, Bridging Health: Biophytis Forges Ahead! Paris and Cambridge Align as Biophytis Unveils Regulatory Momentum for COVA Project. Empowered by EMA and FDA Insights, … Read more

Unlocking the Power of Unity: The Impactful Role of Employee Resource Groups (ERGs) in Cultivating Inclusive Workspaces. Discover How ERGs Drive Employee Engagement, Retention, Recruitment, … Read more

With its cutting-edge cGMP facility in San Francisco Bay Area, GeneFab is ready to take on new customers, offering expertise in complex cell and gene … Read more

We are proud to announce that Comera has advanced to the final stage of technical evaluation in its research collaboration with Regeneron, a top biotechnology … Read more

Reaching new heights, we’ve achieved our goal of investing $1 billion in diverse-owned suppliers – and we’re not stopping there! Our commitment to this important … Read more

In a major step towards advancing precision healthcare and medical treatments, global biotechnology company Rakuten Medical, Inc. has entered into an exclusive licensing and commercialization … Read more

Daxor Corporation, an innovative leader in blood volume measurement technology, recently published a research paper in the Journal of the American College of Cardiology – … Read more

Despite an uncertain political climate and global economic trends, the job market in the US is still soaring. The unemployment rate currently sits at a … Read more

J&J takes the fast lane to cancer treatment! Its new drug, a bispecific antibody, has been granted accelerated approval from the Food and Drug Administration … Read more

The FDA dealt a crushing blow to Galera Therapeutics Wednesday, rejecting its proposed treatment for radiotherapy-induced severe oral mucositis in patients with head and neck … Read more

Illumina recently revealed that its expected revenue growth for FY2023 has dropped drastically from an initial forecast of 7-10%, to now just a 1% increase. … Read more

In a move that further betters its already vast obesity and diabetes portfolio, Novo Nordisk on Thursday staked over $1 billion on the acquisition of … Read more

Mirum Pharmaceuticals, Inc. welcomed six new employees to the team on August 10, 2023, with special inducement awards to show appreciation. The awards include non-qualified … Read more

Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) announced today its plans to release its second quarter 2023 financial results on Monday, August 14, … Read more

China Pharma Holdings, Inc. (NYSE American: CPHI), a leading specialty pharmaceutical company, is delighted to announce the successful approval for its candesartan tablets from the … Read more

On August 8, 2023, T2 Biosystems, Inc (NASDAQ:TTOO) received notice from the NASDAQ Stock Market LLC that its market value of listed securities was once … Read more

Inteleos, a leading non-profit global healthcare certification organization, is pleased to announce the newest addition to their team – Jasmine Rockett. In her new role … Read more

Form Bio, the game-changing AI-enabled drug finding platform, proudly shared its noteworthy accomplishments and significant product advancements for the first half of this year. With … Read more

After studying the initial Phase I findings of an experimental Alzheimer’s therapy, Takeda and Denali Therapeutics have concluded that the treatment had a “narrow therapeutic … Read more

Despite the hampered state of its finances, bluebird bio remains steadfast in its operations through the end of 2021. Massachussetts-based gene therapy company announced the … Read more

Novartis has just made a giant leap forward in its quest to become a leader in the chronic spontaneous urticaria market. On Thursday, the Swiss … Read more

Regeneron Pharmaceuticals, a New York-based biotech, is investing in its long-term partnership with Decibel Therapeutics with the purchase of the company for $109 million. The … Read more

Mirati Therapeutics set a course for a new leadership chapter on Tuesday, with founder and president Charles Baum taking the reins of the company while … Read more

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research (CEBR), is confident in the OTP’s progress towards filling their 500 vacancies. He … Read more

Novo Nordisk’s Wegovy (semaglutide) has achieved its primary efficacy standard in the Phase III SELECT study, showing a robust effect on cardiovascular well-being in overweight … Read more

Novavax, the embattled vaccine maker, scored a surprising victory this week, announcing $58 million in net income for the second quarter of the year—a major … Read more

Mirati Therapeutics, Inc. (Nasdaq: MRTX), a commercial stage biotechnology company, announced the pricing of an underwritten public offering of 9,669,631 shares of common stock at … Read more

Pharming Group N.V. is pleased to announce that the first patient has successfully been enrolled in its groundbreaking Phase III clinical trial to evaluate leniolisib … Read more

Novozymes has delivered an impressive 3% organic sales growth, despite a turbulent environment. The full-year organic sales growth outlook for 2023, however, has been slightly … Read more

SK bioscience is taking the fight against the COVID-19 pandemic to the next level with a strategic equity investment into Novavax to bolster their partnership … Read more

GeneDx, an innovator in delivering improved health solutions through genetic and clinical knowledge, today announced that it has granted new employees 23,769 restricted stock units … Read more

Benitec Biopharma Inc. (Nasdaq: BNTC) is delighted to announce the pricing of its underwritten public offering, comprising 15,544,041 shares of its common stock, along with … Read more

In response to the looming threat of price-negotiating by the federal government, major biopharmaceutical companies have begun to abandon costly drug programs. This has provoked … Read more

Despite initial impressions, experts warn the Inflation Reduction Act may not be good news for biological products after all, given their past performance in the … Read more

GT Biopharma, Inc., an immuno-oncology firm pioneering revolutionary treatments utilizing its TriKE® platform, has released its second quarter 2023 financial data for the period of … Read more

Keros Therapeutics, Inc. (KROS) revealed its financial results for the quarter ended June 30th, 2023 along with delivering a comprehensive business update. The clinical-stage biopharmaceutical … Read more

Kytopen, a biotechnology company at the forefront of advanced cell engineering solutions, has announced the appointment of Michael Chiu, Ph.D., as its Chief Executive Officer. … Read more

Vincerx Pharma Inc. (Nasdaq: VINC), a pioneering biopharmaceutical company striving to improve the lives of cancer patients by providing innovative treatments, announced its financial results … Read more

180 Life Sciences Corp. (NASDAQ: ATNF) has recently struck a deal with Prof. Avi Domb from Hebrew University’s School of Pharmacy and Prof. Elyad Davidson … Read more

Voyager Therapeutics, Inc. (NASDAQ: VYGR) today announced the appointment of Beth Shafer, Ph.D., M.A., M.Phil., as their new Chief Business Officer (CBO). Shafer brings more … Read more

The race to create a successful chikungunya vaccine is intensifying, after Danish biotech Bavarian Nordic announced promising Phase III trial results for its vaccine candidate—marking … Read more

Novartis’ much-hyped sickle cell disease therapy Adakveo (crizanlizumab) has received a stunning blow, as the European Commission has officially withdrawn its conditional marketing authorization. The … Read more

Nektar Therapeutics made an unexpected announcement on Monday – its investigational regulatory T-cell stimulator rezpegaldesleukin (rezpeg) has not been delivering the efficacy data as expected. … Read more

Sage Therapeutics’ stock took a hard nosedive on Monday, dropping 46%, after the Food and Drug Administration (FDA) issued a Complete Response Letter regarding their … Read more

Anixa Biosciences, Inc. (NASDAQ: ANIX) has welcomed a significant milestone in the fight against breast cancer, with partner Cleveland Clinic launching a treatment arm for … Read more

IO Biotech, Inc. (Nasdaq: IOBT) announced today that it has entered into a definitive securities purchase agreement for a private placement, garnering a total of … Read more

Oragenics Inc., a biotech company focused on combating infectious diseases, including those caused by coronaviruses, is thrilled to announce that two healthcare-focused investors have entered … Read more

GERO, a notable AI-driven biotechnology company dedicated to extending life expectancy, and FOXO Technologies Inc., a pioneering epigenetic biomarker explorer and marketer, have announced the … Read more

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) is delighted to announce that the French National Agency for Medicines and Health Products Safety (ANSM) and French National Authority … Read more

Poseida Therapeutics, Inc., a groundbreaking clinical-stage cell and gene therapy company, recently received a $50 million boost from strategic investor Astellas Pharma US, Inc. in … Read more

NS Pharma, Inc. today announced an incredible breakthrough for patients with Duchenne muscular dystrophy: The U.S. Food and Drug Administration (FDA) has granted Orphan Drug … Read more

The potential for the pulmonary arterial hypertension treatments market is huge, with estimates of nearly $11 billion by 2030 – significantly more than the projected … Read more

The European Commission has officially withdrawn its approval of Novartis’ treatment for sickle cell disease, Adakveo (crizanlizumab). The Swiss pharmaceutical behemoth announced the government’s reversal … Read more

Iveric Bio’s cutting-edge intravitreal avacincaptad pegol is now officially available as Izervay, after it just received the FDA’s stamp of approval. This groundbreaking medication is … Read more

Protara Therapeutics, Inc. (Nasdaq: TARA) announced financial results and an update on its progress for the second quarter of 2023 on August 03. Protara is … Read more

Today Ginkgo Bioworks (NYSE: DNA) and the Government of the Republic of Panama’s Gorgas Memorial Institute for Health Studies have joined forces in a groundbreaking … Read more

According to a recent research brief published in the Journal of Managed Care & Specialty Pharmacy, Medicare could be set to save a colossal sum … Read more

A potential revolutionary trifecta of weight loss and type 2 diabetes treatments, glucagon-like peptide-1 receptor agonists have been garnering much attention lately. Not only may … Read more

The FDA has given the green light to Taiho Oncology’s Lonsurf (tipiracil) to be used in tandem with Roche’s Avastin (bevacizumab) as an effective treatment … Read more

Regeneron made a surprise announcement on Thursday that the FDA was poised to make a decision on a higher dose regimen of Eylea (aflibercept) in … Read more

Moderna is fighting back against the impacts of the pandemic, increasing research and development spending despite a dip in revenue. The mRNA biotech released its … Read more

We seek approval for three bacterial infections: Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP). These … Read more

Mesoblast Limited, a global leader in allogeneic cellular medicines for inflammatory diseases, just received a complete response from the US Food and Drug Administration (FDA) … Read more

This ground-breaking agreement seeks to tackle the difficult and long-standing issues surrounding cardiovascular disease. It is aimed at finding effective ways to combat this life-threatening … Read more

Bio, Inc. has been granted an exclusive license to bring to market an innovative diagnostic tool and a promising early-stage treatment for Crohn’s disease. This … Read more

iSpecimen Inc (Nasdaq: ISPC) announced its financial and operating results for the second quarter of 2023, which ended June 30th. The healthcare specimen provider and … Read more

Cambridge, Mass.-based Editas Medicine, Inc. (Nasdaq:EDIT) reported its second quarter 2023 financial results, sharing progress on its clinical-stage gene-editing efforts as well as updates on … Read more

Biotech stocks have endured a punishing bear market for what seems to be an eternity, making it one of the worst periods on record for … Read more

The US Food and Drug Administration (FDA) has raised serious concerns about the quality control practices at Intas Pharmaceuticals’ plant in Sanand, India, going so … Read more

Illumina and Guardant Health are now ready to put the past behind them as they agreed to cease trade secrets litigation. They are now looking … Read more

Vertex Pharmaceuticals has experienced an upsurge in demand for Trikafta, resulting in a 14% surge in product revenues in the second quarter – a development … Read more

On Wednesday, GlaxoSmithKline embarked on an epic legal battle against pharmaceutical giant Pfizer, claiming four breaches of their patents regarding the antigen used in their … Read more

Every year, hundreds of thousands of US veterans are transitioning from their military life to civilian life. The journey of finding a place in the … Read more

Although layoffs are still an all too familiar reality, the demand for talented individuals in the biotech industry has never been higher. Emerging biotechs are … Read more

Last month, the U.S. Federal Trade Commission took a bold step in their efforts to regulate the biopharmaceutical industry, introducing new draft merger guidelines. The … Read more

Novavax, Inc. (Nasdaq: NVAX), a pioneering player in the protein-based vaccines space with its Matrix-M™ adjuvant, is excited to announce that it will report its … Read more

Today, Tyra Biosciences, Inc. (Nasdaq: TYRA), a California-based clinical-stage biotechnology company that’s developing cutting-edge precision medicines targeting large opportunities in Fibroblast Growth Factor Receptor (FGFR) … Read more

The NExT Program is on a mission to revolutionize clinical practices and treatments for cancer patients. This unique translational research undertaking seeks to develop promising … Read more

RevBio, Inc. is thrilled to announce that it has been granted approval from the U.S. Food and Drug Administration for a 20-patient clinical trial to … Read more

AltruBio Inc., a biotech company revolutionizing the treatment of immune-related diseases, has announced hugely encouraging topline results from its first clinical trial of its subcutaneous … Read more

Francis Medical, Inc., a privately held medical device company, is celebrating a major milestone – the U.S. Food and Drug Administration (FDA) has granted Breakthrough … Read more

Immutep, formerly known as Prima Biomed, is ecstatic to announce a major milestone today in the development of eftilagimod alpha (efti). The Committee for Medicinal … Read more

At Scientia Clinical Research, our research team has made incredible progress in evaluating the safety and efficacy of the RECCE® 327 (R327) drug. We completed … Read more

scPharmaceuticals Inc. (Nasdaq: SCPH), a revolutionary pharmaceutical company dedicated to improving the delivery of infused therapies, advancing patient care and reducing healthcare costs, has just … Read more

IntelGenx Corp (TSX:IGX)(OTCQB:IGXT) has finalized enrollment in its Phase 2a (“BUENA”) clinical trial for Montelukast VersaFilm®, a potential treatment for mild to moderate Alzheimer’s Disease … Read more

A whirlwind of activity has been seen in the first half of 2023, as the FDA has already approved a record 28 new treatments. This … Read more

Do you want to know your risk of developing Alzheimer’s disease? On Monday, Quest Diagnostics launched the AD-Detect Test to offer a direct-to-consumer blood test … Read more

The U.S. Food and Drug Administration (FDA) recently gave its stamp of approval to GSK’s Jemperli (dostarlimab-gxly), a new treatment for women suffering from primary … Read more

Revolution Medicines, Inc. has just announced an ambitious acquisition of troubled Massachusetts-based biotech firm EQRx, in an all-stock transaction that would skyrocket its net cash … Read more

AstraZeneca has reached a stunning resolution to their long-running patent-infringement battle against top competitor Bristol-Myers Squibb with a hefty $510 million payout. This significant settlement … Read more

Pfizer had a disappointing second quarter, reporting lower-than-predicted revenue due to the pandemic’s impact on sales. Even more disappointingly, the company has had to cut … Read more

Biotech has suffered severely during the longest bear market in recent memory, prompting investors to re-examine their portfolios and consider alternative strategies. The biotech industry … Read more

The Federal Trade Commission recently proposed new draft merger guidelines in an effort to reign in acquisitions in the biopharmaceutical industry and put them under … Read more

Hospital for Special Surgery (HSS) has achieved an unprecedented feat – it has been ranked as the number one hospital for orthopedics in the United … Read more

Leads Biolabs is proud to announce today that its first-in-human Investigational New Drug (IND) application for LBL-034, an anti-GPRC5D/CD3 bispecific antibody, has been approved by … Read more

TC BioPharm, a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, is pleased to announce that it has successfully regained … Read more

NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company focused on creating revolutionary treatments for stroke and traumatic brain injury victims, is pleased to announce the … Read more

T2 Biosystems Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, has been given a reprieve today after the … Read more

PharmAla Biotech Holdings Inc., a biotechnology leader in the research, development, and manufacturing of novel MDXX class molecules, is thrilled to announce the filing of … Read more

MAGENTIQ-EYE LTD., a revolutionary technology company founded in 2014, is thrilled to announce that it has received FDA clearance via the 510(k) process for its … Read more

Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage company pioneering macrophage reprogramming immunotherapy, has announced great news for their Phase II trial evaluating Allocetra™ in patients … Read more

Mustang Bio, Inc. (Nasdaq: MBIO) is thrilled to announce that on July 28, 2023, it has successfully amended and closed the transaction for an asset … Read more

60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq: SXTP) is thrilled to announce that the Canadian Intellectual Property Office (CIPO) has granted them a … Read more

The race to find a groundbreaking treatment for non-alcoholic steatohepatitis is heating up, as multiple companies like Madrigal Pharmaceuticals, Hepion Pharmaceuticals, and 89Bio vie to … Read more

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company committed to advancing precision medicine for neurodegenerative diseases, today announced that their team will participate in … Read more

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) is thrilled to announce it has entered into an agreement to purchase and sell 7 million shares of its … Read more

Sanofi is excited to announce the acquisition of Qunol®, a U.S.-based, market-leading brand in health and wellness. This acquisition bolsters Sanofi’s Consumer Healthcare’s (CHC) Vitamin, … Read more

Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”) is delighted to announce the appointment of the highly experienced … Read more

Inozyme Pharma, Inc., the clinical-stage biopharmaceutical company, has announced a public offering of 12.5 million shares of its common stock at a price of $4.80 … Read more

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is thrilled to announce that, on July 27, 2023, the Board of Directors’ Compensation Committee granted two newly hired employees … Read more

Palliare, a pioneer in advanced insufflation technology, has achieved a major milestone in its mission to provide superior medical care solutions. The company recently obtained … Read more

Natera, Inc. (NASDAQ: NTRA), a pioneering leader in cell-free DNA testing, is proud to announce the completion of enrollment for its cutting-edge ALTAIR clinical trial. … Read more

Nutromics is excited to announce the formation of its Biosensor Advisory Board, featuring the world-renowned expertise of leading scientists from US and Australian institutions. Led … Read more

The European Commission has granted Curium, a world leader in nuclear medicine, approval to market PYLCLARI™, formerly known as (18F)-DCFPyL. This PET-based drug is used … Read more

CoImmune, Inc., a clinical stage immuno-oncology company, has made a breakthrough with their Synthetic Enzyme-Armed Killer (SEAKER) cell therapy for solid tumor melanomas. Their findings, … Read more

In a groundbreaking new study published in the Journal of the National Cancer Institute (JNCI), a collaboration between GC Genome Corporation – a leading genomic … Read more

Today marks a major milestone for Everest Medicines (HKEX 1952.HK, “Everest”) with the successful launch of XERAVA® (eravacycline) in China. The first prescription of XERAVA® … Read more

Bio-Rad Laboratories, Inc. (NYSE:BIO and BIOb) and QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard: QIA) have reached a settlement in their long-standing patent dispute in the … Read more

Kriya Therapeutics, Inc., a groundbreaking biopharmaceutical company, just clinched a major victory in its efforts to bring disruptive gene therapies to the world. After raising … Read more

Viage Therapeutics’ DGX-001, an innovative oral therapeutic made to target the AVPR1A receptor in the gut, soared to incredible success after its Phase 1 study’s … Read more

Today, international venture capital firm TVM Capital Life Science (“TVM”) and specialty pharma company Tillotts Pharma (“Tillotts”) have announced a joint investment of up to … Read more

Nexo Therapeutics has today unveiled sweeping changes with a dramatic $60 million Series A funding round led by founding investor Versant Ventures, New Enterprise Associates, … Read more

ExThera Medical, the developer of the revolutionary Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100), is proud to welcome Michael DiMeo as Chief Financial Officer! … Read more

Circle Pharma, Inc., a leading biopharmaceutical company specializing in the discovery and development of therapeutically potent macrocycles that can permeate cells, is proud to announce … Read more

PharmAbcine Inc. (KOSDAQ: 208340ks) is thrilled to announce the first patient in the Phase I clinical trial of PMC-403, its groundbreaking TIE2 agonistic antibody, has … Read more

Humacyte, Inc., a clinical-stage biotechnology platform company (NASDAQ: HUMA), has completed enrollment of its Phase 2/3 vascular trauma trial, taking a monumental step forward toward … Read more

Organicell Regenerative Medicine, Inc. (OTCQB:OCEL) has just announced the successful results of its Phase 1/2A research program for its biologic therapeutic, ZofinTM. ZofinTM is composed … Read more

Dr. Amol Soin, of Soin Neuroscience, a Dayton, OH based biotech startup, has unveiled its new TunedTX platform. This revolutionary spinal cord stimulator system provides … Read more

Yesterday, the U.S. Food and Drug Administration (FDA) granted revolutionary hope for sufferers of Demodex blepharitis with the approval of XDEMVY™ (lotlilaner ophthalmic solution) 0.25%. … Read more

Octave Bioscience, a precision care innovator that is revolutionizing the standard of care for people with multiple sclerosis (MS) and other neurodegenerative diseases, today announced … Read more

MyoPax has achieved a major breakthrough in Exstrophy-Epispadias Complex (EEC) treatment, with the U.S. Food and Drug Administration (FDA) granting it Orphan Drug Designation. The … Read more

AbbVie (NYSE: ABBV) and Calibr are pleased to announce an expansion of their successful strategic collaboration, which aims to develop innovative therapeutics across AbbVie’s core … Read more

Yield10 Bioscience, Inc. (Nasdaq:YTEN) recently announced their request for a Regulatory Status Review (RSR) with USDA-APHIS Biotechnology Regulatory Services (BRS). This request is for the … Read more

Rece Pharmaceuticals Ltd. (ASX: RCE, FSE: R9Q) is excited to announce that their clinical trial for a new category of synthetic anti-infectives to be used … Read more

The European Commission (EC) has just given their stamp of approval to Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease (CKD). This … Read more

Hoth Therapeutics, Inc. (NASDAQ: HOTH) is delighted to announce that the initial patient has been dosed in Phase 2a of their HT-001 therapy for skin … Read more

Third Harmonic Bio, Inc. (Nasdaq:THRD) is on the brink of bringing forward a revolutionary medicine to treat inflammatory diseases. In an exciting turn of events, … Read more

Experience the speed and accuracy of molecular diagnostics across institutions of any size, from small clinics to high-volume hospitals, with Anbio’s comprehensive RT-PCR solution. Anbio’s … Read more

LSPedia, a SaaS provider specializing in product traceability solutions for the pharmaceutical industry, teams up with Altro Pharmaceuticals to help their customers easily comply with … Read more

BioSig Technologies Inc. (NASDAQ: BSGM) has achieved another milestone with the completion of a successful seed funding round raising $2.2 million for its subsidiary, BioSig … Read more

Avenue Therapeutics, Inc. (Nasdaq: ATXI) is pleased to announce that they have reached a milestone agreement with the U.S. Food and Drug Administration (“FDA”) on … Read more

The Parkinson’s Disease Foundation has just granted nearly $1 million to various local programs aiming to provide support and improve the lives of those affected … Read more

Blue Earth Diagnostics, a renowned company in the development and commercialization of innovative PET radiopharmaceuticals, is delighted to announce that its POSLUMA® (flotufolastat F 18) … Read more

Bryn Pharma, LLC, the innovative pharmaceutical company committed to revolutionising the way patients and carers approach type 1 anaphylactic reactions, is proud to welcome its … Read more

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company with a focus on the development of pioneering cell and exosome-based therapeutics, has welcomed Philip J. Gotwals, Ph.D. … Read more

BioCardia, Inc. [Nasdaq: BCDA] is thrilled to announce that the Data Safety Monitoring Board (DSMB) has completed their review of the Phase III CardiAMP® Cell … Read more

Cabaletta Bio, Inc. (Nasdaq: CABA), a cutting-edge biotechnology company developing targeted, curative cell therapies for patients with autoimmune diseases, is pleased to welcome Shawn Tomasello … Read more

Talis Biomedical Corporation (Nasdaq: TLIS) is proud to announce that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) after maintaining a closing bid price … Read more

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA), a clinical stage specialty biopharmaceutical company committed to developing life-saving drugs for treatment of inflammatory and renal diseases, announced the … Read more

Myriad Genetics, Inc. (NASDAQ: MYGN) introduces MyRisk® Hereditary Cancer Test with RiskScore® as the first breast cancer risk model that includes breast density, personal/family clinical … Read more

Crescendo Biologics Ltd is taking exciting steps forward with its clinical trial of CB307, unlocking new possibilities in the fight against cancer. The company has … Read more

Orthogon Therapeutics LLC, a revolutionary force in antiviral therapeutics, is celebrating a double triumph – its lead molecule has aced acute toxicity tests, unlocking an … Read more

The Association for Diagnostics & Laboratory Medicine (formerly the American Association for Clinical Chemistry, or AACC) is thrilled to announce its exciting name change. With … Read more

BioGX is revolutionizing the way healthcare providers test for Candida auris, a rapidly spreading fungus with a global presence in hospitals and long-term care facilities. … Read more

The U.S. Food and Drug Administration (FDA) has just given Invivoscribe’s LeukoStrat® CDx FLT3 Mutation Assay the green light – an exciting development that will … Read more

ImmunityBio, Inc. (NASDAQ: IBRX) has entered into a securities purchase agreement to provide funds for working capital and support its ongoing business operations, with multiple … Read more

Jacobio Pharma (1167.HK) has reason to celebrate as its clinical-stage oncology solutions have been selected for presentation at the 2023 European Society for Medical Oncology … Read more

Turnstone Biologics Corp., a clinical-stage biotechnology company developing new treatments for solid tumors, has successfully priced its initial public offering of 6,666,667 shares of common … Read more

Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II), a company that specializes in cancer monitoring, has achieved an important milestone in the commercialization of DiviTum® TKa in the … Read more

Median Technologies (Euronext Growth – ALMDT) is proud to announce the publication of an initiation report by Portzamparc Groupe BNP Paribas, a preeminent French financial … Read more

Molecure, the biotechnology innovator striving to develop breakthrough medicines to tackle some of the world’s most challenging diseases, is proud to announce that it has … Read more

BioRestorative is excited to explore the potential of Mesenchymal Stem Cells (MSCs) as a source of treatments for many diseases, including diabetes. MSCs are incredibly … Read more

Enzolytics’ subsidiary Biogenysis, Inc. (BGEN) has forged an exciting new partnership with Khalpey AI Lab to discover biomarkers for early-onset Alzheimer’s Disease. Through this collaboration, … Read more

Curium’s groundbreaking PYTHON trial has achieved a major breakthrough in the world of nuclear medicine. The European, multicenter, prospective cross-over study, which compared the efficiency … Read more

Emergex Vaccines Holding Limited (‘Emergex’, or the ‘Company’) is thrilled to announce the successful completion of naNO-COVID, a Phase I clinical trial in Switzerland evaluating … Read more

On July 3, 2023, scPharmaceuticals Inc. (Nasdaq: SCPH) graciously welcomed seven new employees by granting them generous inducement equity grants consisting of stock options that … Read more

LiVeritas Biosciences, Inc. is proud to announce the beta testing of the revolutionary LiLii™ platform – a cutting-edge, fully integrated laboratory ecosystem that leverages LiVeritas® … Read more

Biophytis, a clinical-stage biotechnology company dedicated to developing therapeutics that fight the effects of aging and improve functional outcomes for patients suffering from age-related diseases, … Read more

Verona Pharma plc (Nasdaq: VRNA), a clinical-stage biopharmaceutical company dedicated to advancements in respiratory disease treatments, will reveal its financial results for the second quarter … Read more

Today, Sosei Group Corporation (“the Company”; TSE: 4565) is proud to announce a groundbreaking acquisition; “Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC … Read more

BioCity Biopharma is thrilled to announce that the first patient has now been dosed with its pioneering antibody drug conjugate, BC3195, in a Phase 1a/1b … Read more

HUTCHMED (China) Limited (Nasdaq/AIM: HCM; HKEX: 13) is delighted to share the exciting news that the combination of fruquintinib and sintilimab has been granted Breakthrough … Read more

Bond Biosciences has just announced impressive results from its Phase 1a/b clinical trial involving a groundbreaking new oral treatment for iron overload – BBI-001. The … Read more

Junshi Biosciences, a globally recognizied biopharmaceutical company, is pleased to announce its Supplemental New Drug Application for toripalimab – an anti-PD-1 monoclonal antibody – has … Read more

Elgan Pharma is proud to announce that it has received a substantial grant of €2.36 million ($2.5 million) from the European Innovation Council (EIC) to … Read more

ARMGO Pharma, Inc. has made a revolutionary breakthrough in medicine with its Rycal ARM210, a small molecule drug set to change the treatment of Catecholaminergic … Read more

Santhera Pharmaceuticals (SIX: SANN) has recently closed its exclusive licensing of vamorolone in North America to Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), resulting in a major … Read more

Caris Life Sciences® is thrilled to announce a monumental step forward in revolutionizing healthcare: University Hospitals (UH) Seidman Cancer Center has joined the ranks of … Read more

Culture Biosciences is thrilled to have Eliana Clark, PhD, Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc., join its Advisory Board. This … Read more

Relief Therapeutics, an innovative biopharmaceutical company dedicated to providing breakthrough treatment solutions for specialty and rare diseases, is proud to announce the extension of its … Read more

Hansa Biopharma is on the cusp of making history by becoming the first company to initiate an investigator-initiated phase 2 study to treat anti-neutrophil cytoplasmic … Read more

Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS) today announced the launch of a registered direct offering to purchase 1,333,334 units consisting of one American Depositary … Read more

Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company driven to combatting cancer through innovative immunotherapies, has announced exciting clinical data from its Phase I/II BEXMAB study. … Read more

At the Alzheimer’s Association International Conference® 2023 (AAIC®), Diadem SpA presented a study that further highlighted the potential value of its AlzoSure® Predict blood-based biomarker … Read more

Eli Lilly has made the exciting announcement of full results for their Phase III TRAILBLAZER-ALZ 2 study of donanemab, confirming the positive results previously published … Read more

The Pharming Group N.V. is delighted to announce the nomination of Dr. Richard Peters as its new Chairman of the Board of Directors. Dr. Peters … Read more

Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), (“Biophytis”), an innovative clinical-stage biotechnology firm dedicated to developing therapeutics to retard degenerative processes associated with aging, and … Read more

Antengene Corporation Limited (SEHK: 6996.HK) today announced a major breakthrough as the first patient has been dosed in the United States in the combination portion … Read more

LEX Diagnostics is proud to welcome Dr Heather Danks to its management team as its Chief Technology Officer (CTO). LEX is an innovative leader in … Read more

DTx Pharma, an innovative biotechnology company incubated and invested in by Viva BioInnovator (VBI), recently made headlines when it was acquired by Novartis. Their remarkable … Read more

Mainz Biomed NV (NASDAQ: MYNZ) is proud to announce a commercial partnership with Fugene Genetics, an esteemed provider of genetic testing services in Israel. Established … Read more

SK Biopharmaceuticals has announced their ambitious new strategy that will take them on a bold journey towards becoming a world-renowned industry leader in the field … Read more